1_Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012 Jul;10(7):712-721.e4. doi: 10.1016/j.cgh.2012.02.029. Epub 2012 Mar 15.
2_ J.A.Olmos,G.Iantorno. Irritable bowel syndrome: prevalence, comorbidity and impact: a population based study. UEGW 2010.
3_Agarwal N, Spiegel BM. The effect of irritable bowel syndrome on health-related quality of life and health care expenditures. Gastroenterol Clin North Am. 2011 Mar;40(1):11-9. doi: 10.1016/j.gtc.2010.12.013.
4_El-Serag HB, Pilgrim P, Schoenfeld P. Systemic Review: Natural history of irritable bowel syndrome. Aliment Pharmacol Ther. 2004 Apr 15;19(8):861-70.
5_ Brian E. Lacy,1 Fermín Mearin, et al. Bowel Disorders. Gastroenterology 2016;150:1393–1407.
6_ Chey W, Nojkov B, Rubenstein J, et al. The yield of colonoscopy in patients
with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial. Am J Gastroenterol 2010; 105: 859–65.
7_ Cash B, Schoenfeld P, Chey W. The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol 2002; 97: 2812–9.
8_ Rosa LS Soares. Irritable bowel syndrome: A clinical review. World J Gastroenterol 2014 September 14; 20(34): 12144-12160.
9_ Michael Camilleri, M.D. Peripheral mechanisms in irritable bowel syndrome. N Engl J Med 2012; 367:1626-1635 October 25, 2012. DOI: 10.1056/NEJMra1207068.
10_ Michael Camilleri, Karen Lasch and Wen Zhou. Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. The confluence of increased síndrome permeability, inflammation, and pain in irritable bowel. Am J Physiol Gastrointest Liver Physiol 303:G775-G785, 2012. First published 26 July 2012; doi: 10.1152/ajpgi.00155.2012.
11_ A P Manning, W G Thompson,et al. Towards positive diagnosis of the irritable bowel. British Medical Journal, 1978, 2, 653-654.
12_ Alberto Zolezzi Francis. Las Enfermedades Funcionales Gastrointestinales
y Roma III. REV. GASTROENTEROL. PERÚ 2007; 27: 177-184
13_ Thompson W, Longstreth G, Drossman D, et al. Functional bowel disorders and functional abdominal pain. Gut 1999; 45(Suppl 2): II43–7.
14_ Brandt L, Chey W, Foxx-Orenstein A, et al. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009; 104(Suppl 1): S1 -35.
15_Arnold LM, Clauw DJ, McCarberg BH, FibroCollaborative (2011) Improving the recognition and diagnosis of fibromyalgia. Mayo Clin Proc 86(5):457–464

16_Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C,Goldenberg DL et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia.Report of the multicenter criteria committee. Arthritis Rheum 33(2):160–172
17_Arnold LM1, Bennett RM2, Crofford LJ3, Dean LE4, Clauw DJ5, Goldenberg DL6, et al. AAPT Diagnostic Criteria for Fibromyalgia. J Pain. 2019 Jun;20(6):611-628.
18_ Goldenberg DL (1998) Fibromyalgia and related syndromes.In: Klippel JH, Dieppe PA (eds) Rheumatology. Mosby,Philadelphia, pp 1–12.
19_Bradley LA (2008) Pathophysiologic mechanisms of fibromyalgia and its related disorders. J Clin Psychiatry 69(Suppl 2):6–13
20_ Willam E. Systematic Review of the Comorbidity of Irritable Bowel Syndrome With Other Disorders: What Are the Causes and Implications? Gastroenterology 2002;122:1140-1156
21_Fatemeh Heidari. Prevalence of fibromyalgia in general population and patients, a systematic review and meta‑analysis. Rheumatol Int DOI 10.1007/s00296-017-3725-2
22_Ali Rezaie , Michelle Buresi, Anthony Lembo , Henry Lin  , Richard McCallum ,
Satish Rao, Max Schmulson, Miguel Valdovinos, Salam Zakko, Mark Pimentel. Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus. Am J Gastroenterol 2017; 112:775–784.
23_Jan Bures, Jiri Cyrany, Darina Kohoutova, Miroslav Förstl, Stanislav Rejchrt, Jaroslav Kvetina, Viktor Vorisek, andMarcela Kopacova. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol. 2010 Jun 28; 16(24): 2978–2990.
24_Amit H. Sachdev and Mark Pimentel. Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance. Ther Adv Chronic Dis. 2013 Sep; 4(5): 223–231. doi:  10.1177/2040622313496126. PMCID: PMC3752184.
25_Ghoshal UC, Srivastava D. Irritable bowel syndrome and small intestinal bacterial overgrowth: meaningful association or unnecessary hype. World J Gastroenterol. 2014 Mar 14;20(10):2482-91. doi: 10.3748/wjg.v20.i10.2482.
26_Gasbarrini A, Corazza GR, Gasbarrini G, Montalto M, Di Stefano M, Basilisco G, Parodi A, Usai-Satta P, Vernia P, Anania C, Astegiano M, Barbara G, Benini L,Bonazzi P, Capurso G, Certo M, Colecchia A, Cuoco L, Di Sario A, Festi D, Lauritano C, Miceli E, Nardone G, Perri F, Portincasa P, Risicato R, Sorge M, Tursi A;1ST Rome H2-breath testing consensus conference working group. methodology and indications of H2-breath testing in gastrointestinal diseases: the rome consensus conference. Aliment Pharmacol Ther. 2009 Mar 30;29 Suppl 1:1-49. 
27_ Mahmoud Slim. An insight into the gastrointestinal component of fibromyalgia:
clinical manifestations and potential underlying mechanisms. Rheumatol Int (2015) 35:433–444

28_Pimentel M. Antibiotic Treatment of Constipation-Predominant Irritable
Bowel Syndrome. Dig Dis Sci (2014) 59:1278–1285
29_Pimentel M. A link between irritable bowel syndrome and fibromyalgia
may be related to findings on lactulose breath testing. Ann Rheum Dis 2004;63:450–452.
30_ Pimentel M, Chow EJ, Hallegua D, Wallace D, Lin HC (2001)
Small intestinal bacterial overgrowth: a possible association
with fibromyalgia. J Musculoskelet Pain 9(3):105–113
